KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Capital Leases (2019 - 2024)

Biolife Solutions (BLFS) has disclosed Capital Leases for 6 consecutive years, with $913000.0 as the latest value for Q3 2024.

  • On a quarterly basis, Capital Leases fell 26.96% to $913000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $913000.0, a 26.96% decrease, with the full-year FY2023 number at $1.2 million, up 819.05% from a year prior.
  • Capital Leases was $913000.0 for Q3 2024 at Biolife Solutions, down from $996000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $1.3 million in Q2 2023 to a low of $12000.0 in Q4 2020.
  • A 5-year average of $556312.5 and a median of $322500.0 in 2021 define the central range for Capital Leases.
  • Peak YoY movement for Capital Leases: soared 2325.0% in 2021, then crashed 62.45% in 2023.
  • Biolife Solutions' Capital Leases stood at $12000.0 in 2020, then skyrocketed by 2325.0% to $291000.0 in 2021, then crashed by 56.7% to $126000.0 in 2022, then soared by 819.05% to $1.2 million in 2023, then dropped by 21.16% to $913000.0 in 2024.
  • Per Business Quant, the three most recent readings for BLFS's Capital Leases are $913000.0 (Q3 2024), $996000.0 (Q2 2024), and $1.1 million (Q1 2024).